Insider Buys through Recent OfferingJust saw that some of the bought deal units were picked up by insiders. Kellum (58,824), Bihl (423,530) and Seto (176,470) for a total of 658,824. Guess they wanted to avoid being diluted.
I still have a hard time understanding how they can trade when they have insider knowledge. First, they know the Baxter deal which is fully redacted for public shareholders. They know the details of the Tigris trial intimately whereas the best public shareholders have is it's "encouraging". And they know the ins and outs of the Dialco marketing to potential partners along with how the process of FDA approval is going for home use. The June 30 results are not public but must be known to them. They must also know how the US listing process is going and who is interested in what stateside.
So how can they trade or acquire when they know all this information not yet known by public shareholders? Anyone know what exempts them from what appears to be priveleged information but still they can buy? Nice gig if you can get it.